Azitra is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Francisco D. Salva, with a market cap of $3.9M.
Common questions about Azitra
Azitra is scheduled to report earnings for Q1 2026 on May 12, 2026.
Azitra has approximately 10 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.